Mainz BioMed N.V. | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Mainz BioMed N.V.

BRIEF

published on 11/12/2024 at 15:05, 8 days 22 hours ago

Mainz Biomed Collaborates with Thermo Fisher for Cancer Screening Development

Cancer Screening Mainz Biomed Colorectal Detection Thermo Fisher Partnership Biotech Collaboration
PRESS RELEASE

published on 11/12/2024 at 15:00, 8 days 22 hours ago

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
Mainz Biomed and Thermo Fisher Scientific sign a collaboration agreement for the development of next generation colorectal cancer screening product for global markets

Global Markets Thermo Fisher Scientific Mainz Biomed Collaboration Agreement Colorectal Cancer Screening
BRIEF

published on 10/21/2024 at 14:06, 30 days 23 hours ago

Mainz BioMed Releases Mid-Year 2024 Financial Results

Financial Results FDA Feedback Mainz Biomed ColoAlert® Cancer Detection
PRESS RELEASE

published on 10/21/2024 at 14:01, 30 days 23 hours ago

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
Mainz Biomed reports 4% revenue increase in Mid-Year 2024 Financial Results with 32% decrease in loss from operations. Company highlights successful studies at ASCO and outlines strategic plan for 2025

Financial Results Corporate Update ColoAlert Mainz Biomed EAArly DETECT
BRIEF

published on 10/08/2024 at 14:05, 1 month 12 days ago

Mainz Biomed Sees Surge in Demand for Enhanced ColoAlert Screening

Mainz Biomed Colorectal Cancer Screening Test Enhanced ColoAlert GANZIMMUN Diagnostics
PRESS RELEASE

published on 10/08/2024 at 14:00, 1 month 12 days ago

Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
Mainz Biomed reports increasing demand for enhanced ColoAlert product leading to transition by existing partners to new version, featuring at Medizinische Woche Baden-Baden

ColoAlert Mainz Biomed Partners Demand Medizinische Woche
BRIEF

published on 10/01/2024 at 14:06, 1 month 19 days ago

Mainz Biomed's CEO Projects Substantial Growth and U.S. FDA Trials in 2025

Cancer Diagnostics Mainz Biomed CRC Screening FDA Trials Growth 2025
PRESS RELEASE

published on 10/01/2024 at 14:01, 1 month 19 days ago

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
Mainz Biomed CEO Guido Baechler shares plans for major growth and U.S. FDA trials in 2025, highlighting innovative cancer diagnostics and upcoming clinical developments

Growth Cancer Diagnostics CEO Statement Mainz Biomed FDA Trials
BRIEF

published on 09/18/2024 at 14:06, 2 months 2 days ago

Mainz Biomed Announces Petra Smeltzer Starke as Brand Ambassador

Cancer Screening Early Detection Brand Ambassador Biomed FDA Trial
PRESS RELEASE

published on 09/18/2024 at 14:01, 2 months 2 days ago

Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
Mainz Biomed N.V. announces Petra Smeltzer Starke as Brand Ambassador to focus on early detection awareness for colorectal cancer

Early Detection Mainz Biomed Colorectal Cancer Brand Ambassador Petra Smeltzer Starke

1 2 ... 9

Accesswire

Published on 11/21/2024 at 13:30, 25 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 25 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 55 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 55 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 55 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 40 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 20 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 40 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 49 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 55 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 57 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 35 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE